Literature DB >> 8793934

"Pill esophagitis"--the case of alendronate.

D O Castell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8793934     DOI： 10.1056/NEJM199610033351412

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  7 in total

1.  Upper gastrointestinal ulceration with alendronate.

Authors:  J L Wallace
Journal:  Dig Dis Sci       Date:  1999-02       Impact factor: 3.199

2.  Esophageal ulceration complicating doxycycline therapy.

Authors:  Mohammad A Al-Mofarreh; Ibrahim A Al Mofleh
Journal:  World J Gastroenterol       Date:  2003-03       Impact factor: 5.742

3.  American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of postmenopausal osteoporosis: executive summary of recommendations.

Authors:  Nelson B Watts; John P Bilezikian; Pauline M Camacho; Susan L Greenspan; Steven T Harris; Stephen F Hodgson; Michael Kleerekoper; Marjorie M Luckey; Michael R McClung; Rachel Pessah Pollack; Steven M Petak
Journal:  Endocr Pract       Date:  2010 Nov-Dec       Impact factor: 3.443

4.  American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of postmenopausal osteoporosis.

Authors:  Nelson B Watts; John P Bilezikian; Pauline M Camacho; Susan L Greenspan; Steven T Harris; Stephen F Hodgson; Michael Kleerekoper; Marjorie M Luckey; Michael R McClung; Rachel Pessah Pollack; Steven M Petak
Journal:  Endocr Pract       Date:  2010 Nov-Dec       Impact factor: 3.443

5.  First report of drug-induced esophagitis by deferasirox.

Authors:  Takeshi Yoshikawa; Takeshi Hara; Hiroshi Araki; Hisashi Tsurumi; Masami Oyama; Hisataka Moriwaki
Journal:  Int J Hematol       Date:  2012-05-01       Impact factor: 2.490

Review 6.  A critical review of brand and generic alendronate for the treatment of osteoporosis.

Authors:  Jacques P Brown; Kenneth S Davison; Wojciech P Olszynski; Karen A Beattie; Jonathan D Adachi
Journal:  Springerplus       Date:  2013-10-21

7.  Comparative safety and effectiveness of alendronate versus raloxifene in women with osteoporosis.

Authors:  Yeesuk Kim; Yuxi Tian; Jianxiao Yang; Vojtech Huser; Peng Jin; Christophe G Lambert; Hojun Park; Seng Chan You; Rae Woong Park; Peter R Rijnbeek; Mui Van Zandt; Christian Reich; Rohit Vashisht; Yonghui Wu; Jon Duke; George Hripcsak; David Madigan; Nigam H Shah; Patrick B Ryan; Martijn J Schuemie; Marc A Suchard
Journal:  Sci Rep       Date:  2020-07-06       Impact factor: 4.379
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.